INCRUSE ELLIPTA pdr inh 55 mcg 30 dos
7680650910015
CH-65091
R03BB07
03.04.3.
1 / 3
google
Details
- Product number
- 6509101
- CPT
- -
- Packaging group
- 30
- Unit
- Einzeldose(n)
- Composition
- umeclidinium 62.5 µg ut umeclidinii bromidum, magnesii stearas, lactosum monohydricum, ad pulverem pro dosi, umeclidinium 55 µg pro dosi, doses pro vase 30.
Articles (1)
Incruse Ellipta, einzeldosiertes Pulver zur Inhalation
Einzeldosiertes Pulver zur Inhalation
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
62.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
55.0 UG | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 54.10
Specialties list
Yes
Generic
No
SL addition date:
01/09/2015
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 65091
- Drug name
- Incruse Ellipta, einzeldosiertes Pulver zur Inhalation
- Galenic form
- PUINE
- ATC Code
- R03BB07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/09/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INCRUSE ELLIPTA pdr inh 55 mcg 30 dos
- Description (DE)
- INCRUSE ELLIPTA Inh Plv 55 mcg 30 Dos
- Market launch
- 29/09/2014
- Narcotic (BTM)
- No